LIRRH trial for right-sided colon cancer
Part of Cancer clinical trials.
This trial tests a treatment for people with right-sided colon cancer that has not spread. It aims to see if a specific surgery or approach can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have colon cancer confirmed by a biopsy, located in the right side or first part of the transverse colon.
- Your cancer has not spread to other parts of the body (stage M0).
- You are fit enough for surgery (ASA score III or less).
- You are willing to follow the study plan and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how to treat cancers located near the right bend of the colon (hepatic flexure) or the first part of the transverse colon. It may help patients by testing a specific approach to surgery before and around the time of resection.
This trial tests whether adding a special dye (indocyanine green) during surgery to remove right-sided colon cancer helps the surgeon see and remove more lymph nodes. The goal is to improve cancer removal without adding extra risks.
This trial compares two ways of reconnecting the bowel after removing the right part of the colon in laparoscopic surgery. One method is done inside the body, the other outside; both are standard, and the study aims to see which is better for recovery.
This trial compares two surgical techniques for removing the right side of the colon when cancer is present. The goal is to see if one method leads to better recovery and long-term outcomes, which could help you and others in the future.
This trial is testing a standard way to do right-sided colon removal surgery using keyhole techniques. The goal is to make the surgery more consistent and improve recovery for people with early-stage colon cancer.
This trial compares a more complete surgery (removing the right colon and surrounding tissue more thoroughly) versus the usual right-colon surgery. It aims to see if the more thorough approach improves outcomes for people with non-metastatic right colon cancer.
Hear when a new Ascending Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.